Horizon Bancorp Inc /In/ Amgen Inc Transaction History

Horizon Bancorp Inc /In/

  • $216 Million
  • Q3 2024

A detailed history of Horizon Bancorp Inc /In/ transactions in Amgen Inc stock. As of the latest transaction made, Horizon Bancorp Inc /In/ holds 159 shares of AMGN stock, worth $51,183. This represents 0.02% of its overall portfolio holdings.

Number of Shares
159
Previous 164 3.05%
Holding current value
$51,183
Previous $51,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$309.38 - $337.38 $1,546 - $1,686
-5 Reduced 3.05%
159 $51,000
Q2 2024

Jul 24, 2024
SELL
$262.75 - $319.31 $8,670 - $10,537
-33 Reduced 16.75%
164 $51,000
Q1 2024

Apr 19, 2024
SELL
$268.87 - $324.56 $2,419 - $2,921
-9 Reduced 4.37%
197 $56,000
Q3 2023

Oct 24, 2023
SELL
$218.65 - $271.46 $84,617 - $105,055
-387 Reduced 65.26%
206 $55,000
Q2 2023

Aug 03, 2023
SELL
$214.27 - $253.37 $6,213 - $7,347
-29 Reduced 4.66%
593 $132,000
Q1 2023

May 05, 2023
SELL
$225.79 - $275.2 $17,611 - $21,465
-78 Reduced 11.14%
622 $150,000
Q4 2022

Feb 09, 2023
SELL
$229.03 - $291.01 $421,644 - $535,749
-1,841 Reduced 72.45%
700 $184,000
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $33,320 - $37,054
142 Added 5.92%
2,541 $646,000
Q2 2020

Aug 10, 2020
SELL
$197.81 - $242.74 $91,783 - $112,631
-464 Reduced 16.21%
2,399 $566,000
Q1 2020

Apr 20, 2020
SELL
$182.24 - $241.7 $183,880 - $243,875
-1,009 Reduced 26.06%
2,863 $580,000
Q4 2019

Feb 11, 2020
BUY
$189.21 - $243.2 $732,621 - $941,670
3,872 New
3,872 $933,000

Others Institutions Holding AMGN

# of Institutions
3,082
Shares Held
417M
Call Options Held
7.24M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Horizon Bancorp Inc /In/ Portfolio

Follow Horizon Bancorp Inc /In/ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Bancorp Inc /In/, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Bancorp Inc /In/ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email